Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials

BACKGROUND: This meta-analysis was updated with results from a new trial and final data to reassess the efficacy and safety of bevacizumab combined with chemotherapy in ovarian cancer (OC). METHODS: Randomized controlled trials (RCTs) were searched in PubMed, EMBASE, Cochrane clinical trials, Web of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu Shen, Shui, Lin, Shen, Dan, Chen, Xiaopin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354693/
https://www.ncbi.nlm.nih.gov/pubmed/27793044
http://dx.doi.org/10.18632/oncotarget.12926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354693/
https://www.ncbi.nlm.nih.gov/pubmed/27793044
http://dx.doi.org/10.18632/oncotarget.12926

Ejemplares similares